Literature DB >> 1379048

Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.

T Morodomi1, Y Ogata, Y Sasaguri, M Morimatsu, H Nagase.   

Abstract

The precursor of matrix metalloproteinase 9 (proMMP-9), also known as '92 kDa progelatinase/type IV procollagenase', was purified from the conditioned medium of U937 monocytic leukaemia and HT1080 fibrosarcoma cell lines stimulated with phorbol 12-myristate 13-acetate. ProMMP-9 in these culture media is non-covalently complexed with the 29 kDa tissue inhibitor of metalloproteinases (TIMP), but free proMMP-9 was separated from the TIMP-proMMP-9 complex by chromatography on Green A Dyematrex gel. The final product was homogeneous on SDS/PAGE, with a molecular mass of 88 kDa without reduction and 92 kDa with reduction. Treatment of proMMP-9 with 4-aminophenylmercuric acetate converted the 88 kDa precursor into 80 kDa and 68 kDa forms. Gelatin-containing zymographic analysis showed zones of lysis associated with all three species. However, only the 68 kDa species was shown to be catalytically active by its ability to bind to alpha 2-macroglobulin. In the presence of an equimolar amount of TIMP, only the 80 kDa species was generated by treatment with 4-aminophenylmercuric acetate, but no enzyme activity was detected. This indicates that TIMP binds to the 80 kDa intermediate and inhibits the generation of the active 68 kDa species. Eight endopeptidases (trypsin, chymotrypsin, plasmin, plasma kallikrein, thrombin, cathepsin G, neutrophil elastase and thermolysin) were tested for their ability to activate proMMP-9. Of them, trypsin was the most effective activator of proMMP-9. Only partial activation (10-30%) was observed with plasmin, cathepsin G and chymotrypsin. The active forms generated by trypsin were identified as 80 kDa, 74 kDa and 66 kDa by their abilities to bind to alpha 2-macroglobulin. In the presence of an equimolar amount of TIMP, proMMP-9 was also converted into the same molecular-mass species by trypsin, but they were not proteolytically active. This suggests activated MMP-9 is inhibited by TIMP. Activated MMP-9 digested gelatin, type-V collagen, reduced carboxymethylated transferrin and, to a lesser extent, type-IV collagen and laminin A chain. The specific activity against gelatin was estimated to be 15,000 units/mg (1 unit = 1 microgram of gelatin degraded/min at 37 degrees C) by titration with alpha 2-macroglobulin. Comparative studies on digestion of gelatin and collagen types IV and V by MMP-9 and MMP-2 indicated that both enzymes degrade these substrates into similar fragments. However, the susceptibilities of laminin, fibronectin and reduced carboxymethylated transferrin to these two MMPs were sufficiently different to indicate differences in substrate specificities between these two closely related proteinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379048      PMCID: PMC1132831          DOI: 10.1042/bj2850603

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

2.  Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.

Authors:  G Murphy; C G McAlpine; C T Poll; J J Reynolds
Journal:  Biochim Biophys Acta       Date:  1985-09-20

3.  Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages.

Authors:  C L Mainardi; M S Hibbs; K A Hasty; J M Seyer
Journal:  Coll Relat Res       Date:  1984-12

4.  Presence of a gelatin-specific proteinase and its latent form in human leucocytes.

Authors:  I Sopata; A M Dancewicz
Journal:  Biochim Biophys Acta       Date:  1974-12-29

5.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

6.  Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.

Authors:  H Nagase; J J Enghild; K Suzuki; G Salvesen
Journal:  Biochemistry       Date:  1990-06-19       Impact factor: 3.162

7.  Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.

Authors:  M S Hibbs; J R Hoidal; A H Kang
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  Human plasma kallikrein. A rapid purification method with high yield.

Authors:  H Nagase; A J Barrett
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

9.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

10.  Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms.

Authors:  G Murphy; R M Hembry; A M McGarrity; J J Reynolds; B Henderson
Journal:  J Cell Sci       Date:  1989-03       Impact factor: 5.285

View more
  36 in total

1.  Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.

Authors:  Harald Frankowski; Yu-Huan Gu; Ji Hoe Heo; Richard Milner; Gregory J Del Zoppo
Journal:  Methods Mol Biol       Date:  2012

2.  Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.

Authors:  Andrezza N Gonçalves; Cesar A Meschiari; William G Stetler-Stevenson; M Cristina Nonato; Cleidson P Alves; Enilza M Espreafico; Raquel F Gerlach
Journal:  J Biotechnol       Date:  2011-10-05       Impact factor: 3.307

Review 3.  Apoptosis in amphibian organs during metamorphosis.

Authors:  Atsuko Ishizuya-Oka; Takashi Hasebe; Yun-Bo Shi
Journal:  Apoptosis       Date:  2010-03       Impact factor: 4.677

4.  Tipping the extracellular matrix balance during heart failure progression: do we always go right?

Authors:  Ying Ann Chiao; Yu-Fang Jin; Merry L Lindsey
Journal:  Cardiology       Date:  2010-07-02       Impact factor: 1.869

Review 5.  Extracellular matrix roles during cardiac repair.

Authors:  Claude Jourdan-Lesaux; Jianhua Zhang; Merry L Lindsey
Journal:  Life Sci       Date:  2010-07-27       Impact factor: 5.037

6.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

7.  A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.

Authors:  Estefanía Ugarte-Berzal; Elvira Bailón; Irene Amigo-Jiménez; Cidonia L Vituri; Mercedes Hernández del Cerro; María José Terol; Juan P Albar; Germán Rivas; José A García-Marco; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

8.  A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.

Authors:  Estefanía Ugarte-Berzal; Elvira Bailón; Irene Amigo-Jiménez; Juan Pablo Albar; José A García-Marco; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

9.  Choriodecidual cells from term human pregnancies show distinctive functional properties related to the induction of labor.

Authors:  Marisol Castillo-Castrejon; Noemí Meraz-Cruz; Nardhy Gomez-Lopez; Arturo Flores-Pliego; Jorge Beltrán-Montoya; Martín Viveros-Alcaráz; Felipe Vadillo-Ortega
Journal:  Am J Reprod Immunol       Date:  2013-11-29       Impact factor: 3.886

10.  Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine].

Authors:  K Naito; S Nakajima; N Kanbayashi; A Okuyama; M Goto
Journal:  Agents Actions       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.